Jeffrey S. Hackman, CEO of Fennec Pharmaceuticals ($FENC), made two open market purchases of common shares totaling about $105,000 in the last year. His most recent buy was on May 19, 2025. These purchases rank 2,106th among 4,983 individual insiders, below the average of $1.5 million per buyer across 3.3 transactions. Hackman reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | M | Common Shares | 1159 | $0.00 | 46,564.0000 | 28,577,000 | 2.55% | 0.00% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | M | Common Shares | 16695 | $0.00 | 45,405.0000 | 28,577,000 | 58.15% | 0.06% |
| March 31, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Stock Options | 200000 | $5.77 | 725,000.0000 | 28,577,000 | 38.10% | 0.70% |
| March 28, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | M | Common Shares | 13943 | $0.00 | 60,507.0000 | 28,577,000 | 29.94% | 0.05% |
| Feb. 18, 2026 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | M | Common Shares | 13710 | $0.00 | 28,710.0000 | 27,889,000 | 91.40% | 0.05% |
| May 16, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | P | Common Shares | 1035 | $6.75 | 1,035.0000 | 27,578,000 | 9999.99% | 0.00% |
| May 19, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | P | Common Shares | 13965 | $6.99 | 15,000.0000 | 27,578,000 | 1349.28% | 0.05% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Stock Options | 50000 | $0.00 | 450,000.0000 | 27,294,000 | 12.50% | 0.18% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Restricted Share Unit | 75000 | $0.00 | 75,000.0000 | 27,294,000 | 9999.99% | 0.27% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Stock Options | 50000 | $0.00 | 525,000.0000 | 27,294,000 | 10.53% | 0.18% |
| March 28, 2025 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Restricted Share Unit | 75000 | $0.00 | 475,000.0000 | 27,294,000 | 18.75% | 0.27% |
| Aug. 15, 2024 | FENNEC PHARMACEUTICALS INC. | $FENC | Hackman Jeffrey S. | Chief Executive Officer | A | Stock Options | 400000 | $5.58 | 400,000.0000 | 27,297,000 | 9999.99% | 1.47% |